Pyridine,4-(4-fluorophenyl)-1,2,3,6-tetrahydro-1-methyl- - Names and Identifiers
Pyridine,4-(4-fluorophenyl)-1,2,3,6-tetrahydro-1-methyl- - Physico-chemical Properties
Molecular Formula | C12H14FN
|
Molar Mass | 191.25 |
Density | 1.079±0.06 g/cm3(Predicted) |
Boling Point | 264.5±40.0 °C(Predicted) |
pKa | 8.63±0.40(Predicted) |
Storage Condition | under inert gas (nitrogen or Argon) at 2-8°C |
Pyridine,4-(4-fluorophenyl)-1,2,3,6-tetrahydro-1-methyl- - Introduction
Paroxetine EP IMpurity G is an IMpurity of Paroxetine according to the European Pharmacopoeia, it is a specific impurity that can be present in paroxetine formulations.
The current information on the nature of Paroxetine EP IMpurity G is very limited and there is little public Literature discussion. Because it is an impurity of paroxetine, there are relatively few studies describing its chemical properties in detail.
Regarding the use of Paroxetine EP IMpurity G, it can be speculated that it is an impure substance produced during the specific synthesis of Paroxetine. However, due to the lack of relevant information, it is not possible to describe exactly its purpose.
regarding the preparation method, the published literature on the preparation method of Paroxetine EP IMpurity G is also very limited. In general, the method of preparing a specific impurity will be designed and optimized according to the chemical structure of the target compound and the reaction conditions. However, a detailed understanding of the preparation method of Paroxetine EP IMpurity G is currently lacking.
Regarding safety information, due to the relatively unknown nature of Paroxetine EP IMpurity G, there is a lack of relevant toxicological and safety evaluation data. Therefore, it is impossible to accurately evaluate its safety on the human body.
In summary, Paroxetine EP IMpurity G is a specific IMpurity present in Paroxetine preparations, but due to the lack of relevant information, its properties, uses, specific knowledge of legal and safety information is very limited. Further experiments and analyses are needed in the study and evaluation of Paroxetine EP IMpurity G. It is recommended to consult the drug manufacturer or relevant specialist for more detailed and accurate information.
Last Update:2024-04-09 21:54:55